Form 4 for GEHC GE HealthCare
Accepted 2024-05-23 00:00:00 ET · period of report 2024-05-21 · accession 0001628280-24-024967 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-23 | 2024-05-21 | GEHC | LESJAK CATHERINE A | Dir | A - Grant | $0.00 | +2,440 | 6,024 | +68% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 per share | 2024-05-21 | A | A | 2,440 | $0.00 | 6,024 | D | — | — | (F1) Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 21, 2025. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the director's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. (F2) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. |